Epilepsy due to potential loss of ATP6V1B2 function with mechanistic insight by a Drosophila Vha55 model

Abstract ATP6V1B2 encodes the subunit of the vacuolar H + ‐ATPase, which is an enzyme responsible for the acidification of intracellular organelles and essential for cell signaling and neurotransmitter release. The aim of the study is to identify the correlation between ATP6V1B2 and epilepsy. Trio‐exome sequencing was performed. Reverse Transcription‐PCR and Quantitative real‐time PCR analyses were carried out to determine whether this variant leads to nonsense‐mediated mRNA decay (NMD). Drosophila models with knocked‐down homologous genes of ATP6V1B2 were generated to study the causal relationship between the ATP6V1B2 and the phenotype of epilepsy. We described a 5‐year‐old male with a novel variant c.1163delT(p.Tyr389IlefsTer13) in ATP6V1B2 , who presented with epilepsy. The expression level of the premature termination codon (PTC) transcript was normal in the patient, which indicated that NMD evasion existed in the PTC transcript. We generated an animal model using Drosophila to study the knock down effects of Vha55 , which is the ATP6V1B2 ortholog in fly. The Vha55 knockdown flies show seizure‐like behaviors and climbing defects. This study expands the variation spectrum of the ATP6V1B2 gene. Cross‐species animal model demonstrates the causal relationship between ATP6V1B2 defect and epilepsy, and shed new insights into the disease mechanism caused by ATP6V1B2 LOF variants.